London (United Kingdom) – Stallergenes Greer plc (the “Company”) (Euronext Paris: STAGR), a biopharmaceutical company specializing in treatments for respiratory allergies, today announced the appointment of Tibor Nemes as Global Head of Technical Operations.
Tibor has 20 years of Operations experience in the biotech and pharmaceutical industry in both Europe and in the United States with a proven track record of leadership in engineering, process development and the manufacturing of biologics, solids, and sterile dosage forms. Since 2008, he held roles of increasing responsibility at Novartis most recently heading Operations for Manufacturing Strategy and Business Development & Licensing within Global Technical Operations.
Fereydoun Firouz, Chairman and Chief Executive Officer of Stallergenes Greer, said:
“I am delighted to welcome Tibor as our Global Head of Technical Operations. Given his background and the recent challenges at our Antony site, the timing of his arrival at Stallergenes Greer is ideal. In this new role, Tibor will lead our Technical Operations organization, craft our global manufacturing strategy, and ensure our teams execute to the highest standards of operational excellence. He will play a vital role in helping our Company become the leading biopharmaceutical company focused on enabling people with allergies to live normal lives.”